The following articles (labelled with PubMed ID or TBD) are for your review
| PMID | Data | Article Title | Organization |
|---|
| 10201826 |
24 |
Synthesis of oxytocin antagonists containing conformationally constrained amino acids in position 2. |
Albert Szent-Gy£Rgyi Medical University |
| | 4 |
Vasopressin trisulphide: synthesis, NMR study and affinity studies with V1 and V2 subtypes receptors |
TBA |
| 14695824 |
68 |
Synthesis and structure-activity relationships of 5,6,7,8-tetrahydro-4H-thieno[3,2-b]azepine derivatives: novel arginine vasopressin antagonists. |
Central Pharmaceutical Research Institute |
| 8258821 |
491 |
Nanomolar-affinity, non-peptide oxytocin receptor antagonists. |
Merck Research Laboratories |
| 2416923 |
40 |
Arginine-vasopressin analogues with high antidiuretic/vasopressor selectivity. Synthesis, biological activity, and receptor binding affinity of arginine-vasopressin analogues with substitutions in positions 1, 2, 4, 7, and 8. |
TBA |
| 2163451 |
45 |
Cyclic hexapeptide oxytocin antagonists. Potency-, selectivity-, and solubility-enhancing modifications. |
Merck Sharp & Dohme Research Laboratories |
| 1331449 |
268 |
Orally active, nonpeptide oxytocin antagonists. |
Merck Research Laboratories |
Search and Browse
